Related Experiment Videos
MicroRNA Expression Profiling in Behçet's Disease.
Antonio Puccetti1,2, Andrea Pelosi1, Piera Filomena Fiore1
1Immunology Area, Pediatric Hospital Bambino Gesù, Viale San Paolo 15, 00146 Rome, Italy.
Journal of Immunology Research
|June 2, 2018
Summary
Researchers identified specific microRNA (miRNA) expression signatures in Behçet's disease (BD) patients. These findings offer insights into the epigenetic factors of BD, potentially leading to new biomarkers and therapies.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Behçet's disease (BD) is a chronic, multisystem inflammatory disorder.
- MicroRNAs (miRNAs) are crucial regulators of immune responses.
- The specific role of miRNAs in BD pathogenesis remains unclear.
Purpose of the Study:
- To identify miRNA expression signatures in BD.
- To explore the potential role of these miRNAs in BD pathogenesis.
Main Methods:
- MicroRNA microarray analysis of blood cells from BD patients and healthy controls.
- Affymetrix array analysis for comprehensive miRNA profiling.
- Pathway and network analyses integrating miRNA and transcriptoma data.
- Validation of selected miRNA deregulation using real-time PCR.
Main Results:
- Specific miRNA signatures associated with active BD were identified.
- These miRNAs target key pathways implicated in BD, including TNF, IFN gamma, and VEGF-VEGFR signaling.
- Network analysis highlighted miRNAs regulating highly connected genes in the BD transcriptome.
Conclusions:
- Combined miRNA and transcriptome analysis reveals epigenetic insights into BD.
- Identified miRNAs show promise as potential biomarkers for BD.
- These miRNAs may guide the development of novel therapeutic strategies for BD.